Free Trial

Veradigm (NASDAQ:MDRX) Shares Gap Up - What's Next?

Veradigm logo with Business Services background

Veradigm Inc. (NASDAQ:MDRX - Get Free Report) shares gapped up before the market opened on Wednesday . The stock had previously closed at $4.60, but opened at $5.10. Veradigm shares last traded at $4.65, with a volume of 10,834 shares traded.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen started coverage on shares of Veradigm in a research note on Tuesday, May 20th. They issued a "hold" rating on the stock.

View Our Latest Stock Analysis on MDRX

Veradigm Trading Down 4.8%

The company's 50 day simple moving average is $4.53 and its 200-day simple moving average is $5.12.

Veradigm Company Profile

(Get Free Report)

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.

Read More

Should You Invest $1,000 in Veradigm Right Now?

Before you consider Veradigm, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Veradigm wasn't on the list.

While Veradigm currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore
AI Stocks Are Printing Money — These 3 Are Just Getting Started

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines